Offer - Urjas Oil for just ₹ 1
Phosmid 200 Injection is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Ovarian Cancer, Multiple Myeloma. Other than this, Phosmid 200 Injection has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Phosmid 200 Injection is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Phosmid 200 Injection as well, which are listed below. Usually, these side effects of Phosmid 200 Injection go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Phosmid 200 Injection's effect during pregnancy is Severe and Severe while nursing. It is important to know if Phosmid 200 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Phosmid 200 Injection related warnings section.
Other contraindications of Phosmid 200 Injection have been discussed in the sections ahead.
Drug reaction of Phosmid 200 Injection with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Phosmid 200 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Phosmid 200 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
| Geriatric |
|
| Adult |
|
Is the use of Phosmid 200 Injection safe for pregnant women?
Phosmid can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Phosmid 200 Injection safe during breastfeeding?
Phosmid should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Phosmid 200 Injection on the Kidneys?
Phosmid rarely affects the kidneys.
What is the effect of Phosmid 200 Injection on the Liver?
Phosmid has very mild side effects on the liver.
What is the effect of Phosmid 200 Injection on the Heart?
Side effects of Phosmid rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Phosmid 200 Injection unless your doctor advises you to do so -
Is this Phosmid 200 Injection habit forming or addictive?
No, you will not get addicted to Phosmid 200 Injection.
Is it safe to drive or operate heavy machinery when consuming?
After taking Phosmid 200 Injection, you should not drive or work on any heavy machine, as Phosmid 200 Injection can make you drowsy.
Is it safe?
Yes, Phosmid 200 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Phosmid 200 Injection for mental disorders.
Interaction between Food and Phosmid 200 Injection
Taking Phosmid 200 Injection with food is safe.
Interaction between Alcohol and Phosmid 200 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Phosmid 200 Injection.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyclophosphamide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 860
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 375-377
